Dantal, Jacques <br/><br/>
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  09 2018 
 - 2612-2620 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.76.6691  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Calcineurin Inhibitors--adverse effects<br/>Carcinoma, Squamous Cell--immunology<br/>Humans<br/>Immunocompromised Host--drug effects<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation<br/>Secondary Prevention--methods<br/>Sirolimus--therapeutic use<br/>Skin Neoplasms--immunology<br/>Transplant Recipients